Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A US health panel advises starting mammograms at age 40 rather than 50.

2.

Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer

3.

Cancer Deaths Fall, Cases Rise; Diabetes and Cancer Risk; Vitamin C for Cancer

4.

Spicy Chip Death Lawsuit; Gen X and Cancer; Extreme U.S. Temperatures

5.

Distribution of fat could influence cancer risk, study suggests


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot